Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF, Messchendorp AL, de Vries RD, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Geers D, Schmitz KS, GeurtsvanKessel CH, den Hartog G, Kho MML, Koopmans MPG, van der Molen RG, Remmerswaal EBM, Rots N, Gansevoort RT, Bemelman FJ, Hilbrands LB, Reinders MEJ; VACcination Immune Response Study (RECOVAC) Collaborators. Sanders JF, et al. Among authors: van binnendijk r, van der molen rg, van baarle d. Clin Infect Dis. 2023 Feb 8;76(3):e188-e199. doi: 10.1093/cid/ciac557. Clin Infect Dis. 2023. PMID: 35796536 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 34038554
The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.
Kho MML, Reinders MEJ, Baan CC, van Baarle D, Bemelman FJ, Diavatopoulos DA, Gansevoort RT, van der Klis FRM, Koopmans MPG, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Hilbrands LB, Sanders JF; RECOVAC Collaborators. Kho MML, et al. Among authors: van der molen rg, van der klis frm, van baarle d. Nephrol Dial Transplant. 2021 Aug 27;36(9):1761-1764. doi: 10.1093/ndt/gfab186. Nephrol Dial Transplant. 2021. PMID: 34450647 Free PMC article. No abstract available.
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Frölke SC, Geers D, GeurtsvanKessel CH, den Hartog G, van der Heiden M, Imhof C, Kho MML, Koopmans MPG, Malahe SRK, Mattheussens WB, van der Molen R, van Mourik D, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Gansevoort RT, Hilbrands LB, Reinders MEJ; RECOVAC Collaborators. Sanders JF, et al. Transplantation. 2022 Apr 1;106(4):821-834. doi: 10.1097/TP.0000000000003983. Transplantation. 2022. PMID: 34753894 Free PMC article.
Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study.
Koenjer LM, Meinderts JR, van der Heijden OWH, Lely T, de Jong MFC, van der Molen RG, van Hamersvelt HW; Members of the PARTOUT network*. Koenjer LM, et al. Among authors: van der heijden owh, van der molen rg, van hamersvelt hw. Transpl Int. 2021 Dec;34(12):2669-2679. doi: 10.1111/tri.14156. Epub 2021 Dec 9. Transpl Int. 2021. PMID: 34797607 Free PMC article.
Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
Bouwmans P, Messchendorp AL, Sanders JS, Hilbrands L, Reinders MEJ, Vart P, Bemelman FJ, Abrahams AC, van den Dorpel MA, Ten Dam MA, de Vries APJ, Rispens T, Steenhuis M, Gansevoort RT, Hemmelder MH; RECOVAC Collaborators. Bouwmans P, et al. BMC Nephrol. 2022 Feb 5;23(1):55. doi: 10.1186/s12882-022-02680-3. BMC Nephrol. 2022. PMID: 35123437 Free PMC article.
SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Imhof C, Messchendorp AL, van der Heiden M, Baan CC, van der Molen RG, Remmerswaal EBM, de Vries RD, Diavatopoulos DA, Boerma A, Bakker FJ, Oosterhout E, Bemelman FJ, Hilbrands LB, Reinders MEJ, Gansevoort RT, Sanders JS, van Baarle D. Imhof C, et al. Among authors: van der heiden m, van der molen rg, van baarle d. Transplant Direct. 2022 Oct 18;8(11):e1387. doi: 10.1097/TXD.0000000000001387. eCollection 2022 Nov. Transplant Direct. 2022. PMID: 36284929 Free PMC article.
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Kho MML, Messchendorp AL, Frölke SC, Imhof C, Koomen VJ, Malahe SRK, Vart P, Geers D, de Vries RD, GeurtsvanKessel CH, Baan CC, van der Molen RG, Diavatopoulos DA, Remmerswaal EBM, van Baarle D, van Binnendijk R, den Hartog G, de Vries APJ, Gansevoort RT, Bemelman FJ, Reinders MEJ, Sanders JF, Hilbrands LB; RECOVAC collaborators. Kho MML, et al. Among authors: van der molen rg, van binnendijk r, van baarle d. Lancet Infect Dis. 2023 Mar;23(3):307-319. doi: 10.1016/S1473-3099(22)00650-8. Epub 2022 Oct 27. Lancet Infect Dis. 2023. PMID: 36354032 Free PMC article. Clinical Trial.
Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses.
den Hartog Y, Malahe SRK, Rietdijk WJR, Dieterich M, Gommers L, Geers D, Bogers S, van Baarle D, Diavatopoulos DA, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Bemelman FJ, Gansevoort RT, Hilbrands LB, Sanders JS, GeurtsvanKessel CH, Kho MML, Reinders MEJ, de Vries RD, Baan CC; RECOVAC Consortium. den Hartog Y, et al. Among authors: van der molen rg. NPJ Vaccines. 2023 May 17;8(1):70. doi: 10.1038/s41541-023-00664-4. NPJ Vaccines. 2023. PMID: 37198189 Free PMC article.
80 results